Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 22 Specimen Handling 20 Magnetic Resonance Spectroscopy 20 pembrolizumab 18 Nivolumab 18 Radiotherapy 17 Biopsy 16 Doxorubicin 15 Temozolomide 14 Radiation 14 X-Rays 9 Irinotecan 9 Ipilimumab 9 Ifosfamide 9 fludarabine 8 Phantoms, Imaging 8 Etoposide 8 cabozantinib 7 Vincristine 7 Carboplatin 7 Bevacizumab 7 regorafenib 6 Sirolimus 6 palbociclib 5 olaparib 5 fludarabine phosphate 5 durvalumab 5 Vinorelbine 5 Sunitinib 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × siremadlin × Sarcoma × Clear all

NCT05180695 2026-02-10

AMPHISARC

Centre Leon Berard

Phase 1/2 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡